A carregar...
Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles
Eye drops containing Tranilast (TL), N-(3,4-dimethoxycinnamoyl) anthramilic acid, are used as an anti-allergic conjunctivitis drug in the ophthalmic field. Traditional eye drops are very patient compliant, although the bioavailability (BA) of most eye drops is low since eye drops cannot be instilled...
Na minha lista:
| Publicado no: | Materials (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178381/ https://ncbi.nlm.nih.gov/pubmed/32260210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ma13071675 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|